AUM Growth & NIM Trajectory in Focus Ahead of Q1 FY27 Print
Cholamandalam Investment heads into Q1 FY27 results riding 20–23% expected AUM growth guidance and ~8% NIM target for the year. Street consensus sits 5–9% above the current mark; watch for evidence the disbursement run-rate and asset quality hold amid recent capital moves.
The Setup: AUM Growth & Capital Strength in Focus
Cholamandalam Investment enters Q1 FY27 results (July 28) on a strong full-year growth footing: management has guided 20–23% AUM growth for FY27 with net interest margin (NIM) anchored around 8%. The July 8 conversion of ₹20,000 Cr in Compulsorily Convertible Debentures (CCDs) into 13.54 lakh equity shares—and ongoing NCD issuances of ₹2,100 Cr—underscore an aggressive capital-raising posture heading into the print. What Street will scrutinize: whether Q1 disbursements hold the pace, asset quality remains benign, and management reiterates the full-year NIM and AUM trajectory despite recent capital dilution.
~₹10.5–11.7 Cr
Q4 FY26 baseline ₹10.5 Cr; seasonally Q1 can run flat to slightly lower
~₹1.3–1.7 Cr
Q4 FY26 was ₹1,626 Cr; Q1 typically lighter post-quarter close; analyst consensus ₹1,500 Cr mid-range
~8.0%
FY27 target; watch for any guidance cut or confidence shift given capital raises
20–23% (FY27)
Street tracking full-year guidance; Q1 disbursement run-rate and pipeline will be key indicator
A strong quarter would show: revenue and PAT at or above consensus (₹11.5 Cr+ revenue, PAT ₹1,550 Cr+), evidence of healthy disbursements, Q1 AUM growth tracking toward full-year 20–23% guide, NIM hold or slight expansion, and stable/low stressed assets. A weak print would flag: revenue or profit materially below consensus, management cutting AUM or NIM guidance, asset quality deterioration signals, or margin compression from competitive pressures. Watch too for commentary on capital adequacy post-conversion and the impact on ROA/ROE.
On Track? Trajectory & Momentum
Cholamandalam's Q4 FY26 saw revenue of ₹10,520 Cr (roughly in line with run-rate) and PAT of ₹1,626 Cr, with management then providing FY27 NIM guidance at ~8% and AUM growth 20–23%. The recent CCD conversion and debt raise signal confidence in both the growth opportunity and capital headroom. Market has responded with analyst consensus lifting to ₹1,800–₹1,887 (27–34 analysts covering), but FII has modestly exited (-1.68pp QoQ), while DII has accumulated (+2.36pp). The stock trades at ₹1,721.5—5–9% below consensus—leaving room for positive surprise if Q1 confirms management's full-year trajectory.
Street View: Consensus & Coverage
Since Last Quarter: Corporate Actions & Filings
Jun 25, 2026
₹2,000 Cr NCDs allotted (unsecured, subordinated redeemable)
NCD Allotment
Jun 18, 2026
₹100 Cr secured NCDs allotted (8.08% coupon, 3-year)
NCD Allotment
Jul 6, 2026
Window closed Jul 1–30 for designated persons (result window)
Trading Window Closure
Jul 8, 2026
₹20,000 Cr CCDs converted to 13.54 lakh equity shares (₹1,476 per share)
CCD Conversion
Jul 6, 2026
48th AGM scheduled Jul 28, 2026, 3:30 PM IST (same day as board result meeting)
AGM Notice
The capital-raising spree—₹2,100 Cr in NCDs + ₹20,000 Cr CCD-to-equity conversion—signals both confidence in growth and preparation for higher lending volumes. No material operational setbacks or insider pledges flagged. Routine disclosure and AGM governance.
What to Watch on Result Day
1 · Disbursement momentum & AUM growth
Q1 disbursement level and AUM growth trajectory vs. FY27 guidance (20–23%). A slowdown here signals demand or competitive headwinds.
2 · Net interest margin (NIM) sustainability
Verify whether NIM holds at or near 8% guidance. Compression would suggest yield pressure or higher funding costs offset by the debt raise.
3 · Asset quality & stressed assets
Watch for any deterioration in stage-2 or stage-3 loans, or uptick in restructuring requests. Benign Q4 asset quality may not persist if credit cycles tighten.
4 · ROA/ROE post-dilution
Post-CCD conversion, share count has increased ~0.16%. Management commentary on return trajectory and accretion timeline will matter to earnings momentum.
5 · Management outlook & guidance reiteration
Reiteration of FY27 AUM growth (20–23%) and NIM (~8%) targets. Any cut or hedging language could spook the Street given recent capital moves.
Cholamandalam Investment reports Q1 FY27 results on July 28 with Street consensus target of ₹1,800–₹1,887 and solid analyst coverage backing a 20–23% AUM growth trajectory. The recent CCD-to-equity conversion and ₹2,100 Cr NCD raises signal management confidence but also introduce dilution to watch. The print will turn on three pillars: evidence that Q1 disbursements hold pace toward full-year AUM guidance, confirmation that NIM remains anchored near 8% despite capital raises, and no material asset-quality deterioration. For a stock trading 5–9% below consensus, a beat on disbursements or strong forward guidance could unlock upside; a stumble on AUM growth or a guidance cut would reverse the recent momentum. This is fundamentally a growth-and-efficiency story: watch whether management can sustain both amid the capital dilution.
Informational and educational content only. Not investment advice.